Author | Christopher T. Ritchlin, MD, MPH

Articles

Psoriatic Arthritis: Expanding Therapeutic Options

May 01, 2011

Article

The therapeutic options for psoriatic arthritis (PsA) have expanded rapidly and improved patients’ pain, function, and quality of life. However, many patients do not respond to the current disease-modifying medications or cannot take them. Oral methotrexate is the leading disease-modifying antirheumatic drug used in PsA.

Psoriatic Arthritis: A Disease in Full

March 05, 2011

Article

The concept of psoriatic arthritis (PsA) has evolved from that of a relatively obscure mild joint disease to that of a severe inflammatory arthritis involving bones, joints, and the surrounding tissue.

x